‘Nation-state’ cyberattack hits Change Healthcare

The latest stories trending on MedCity News.

Editor's Pick

Top Story 'Nation-State' Cyberattack Hits Change Healthcare, Disrupting Pharmacy Services Across the Country Pharmacies across the country are facing disruptions following a cyberattack on Change Healthcare — which is owned by Optum, a subsidiary of UnitedHealth Group. In a filing with the SEC, UnitedHealth stated that the unauthorized party that gained access to Change Healthcare's systems was a "suspected nation-state associated cyber security threat actor." Calling All Women's Health Startups Need more funding? Looking for new partnerships? This is your chance to get in front of healthcare's best industry experts and VCs. Apply to Pitch at INVEST 2024 May 21-22 in Chicago. Winners will receive a $20K branding advertising package. You don't want to miss this opportunity to share how your company is making a difference in biopharma oncology. Deadline to apply is approaching fast, Feb 29th. Apply Now

Featured News

Driving Accessibility in HealthTech: 3 Things Founders should Consider for Thoughtful AI Implementation in 2024 The benefits of artificial intelligence in healthcare are apparent. With careful planning, we can ensure that these developments benefit everyone, leaving no one behind in the goal of a healthier and more equal future. Is AI in Prior Authorization Promising or Dangerous? AI can improve the prior authorization process, but there needs to be more transparency, experts said during a recent panel held by KFF. GSK and Vir Terminate Influenza Alliance a Year After Ending Covid-19 R&D Pact GSK and Vir Biotechnology have ended their influenza collaboration, a move that follows last year's Phase 2 failure for one of the partnered programs. Vir is now free to continue its flu research on its own, but the company says it's actively pursuing other partners.

Resources

MedCity FemFwd: What Male Birth Control Means for Women's Health In this episode of MedCity FemFwd, we were joined by Régine Sitruk-Ware, a distinguished scientist at the Population Council's Center for Biomedical Research (CBR), and Chelsea Polis, senior scientist of epidemiology at CBR. Sitruk-Ware and Polis discuss what the development of a male birth control product could mean for women's health. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe